Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{163840,
        author = {Dr. Ujwala Sandip Dube and Lalit Agrahari and Ishtyak Ansari and Namrata Bhoir and Dr. Smita Takarkhede},
        title = {SURVEY ON UTILIZATION OF BRANDED AND GENERIC MEDICINE},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {10},
        number = {11},
        pages = {2622-2632},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=163840},
        abstract = {In today's healthcare landscape, the use of both branded and generic pharmaceuticals is critical in providing patients around the world with accessible and cost-effective treatment alternatives. The purpose of this survey is to give a thorough examination of the usage trends, attitudes, and consequences related to branded and generic medications across a range of demographic groups. Cost, efficacy, safety, accessibility, physician recommendations, and patient preferences are just a few of the many criteria that are included in the survey that impact the decision between branded and generic drugs. This study aims to determine prevalent patterns and attitudes regarding branded and generic drugs by analyzing responses from a varied sample population, which includes patients, healthcare professionals, chemists, and policymakers.},
        keywords = {Branded Medicine, Generic Medicine, Medication Utilization, Prescription Patterns, Patient Preferences, Cost-Effectiveness, Healthcare Access, Pharmaceutical Industry, Regulatory Policies, Physician Recommendations, Patient Perceptions, Healthcare Disparities, Drug Affordability, Medication Adherence, Healthcare Economics.},
        month = {},
        }